Search research articles
Contact Us
Filters
Showing results (421-430 of 760) with videos related to
Page
of 76
Sort By:
Thrombosis Research
|
July 16, 2014
The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: a retrospective analysis of the FEATHER study
Joseph A Jakubowski, Dominick J Angiolillo, Chunmei Zhou, et al.
Journal of the American Heart Association
|
March 31, 2017
Impact of Diabetes Mellitus on the Pharmacodynamic Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Acute Coronary Syndrome Patients Undergoing Ad Hoc Percutaneous Coronary Intervention
Joseph M Sweeny, Dominick J Angiolillo, Francesco Franchi, et al.
Seminars in Thrombosis and Hemostasis
|
October 12, 2022
COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment
Luis Ortega-Paz, Azita H Talasaz, Parham Sadeghipour, et al.
Thrombosis and Haemostasis
|
March 25, 2016
Diabetes mellitus, CYP2C19 genotype, and response to escalating doses of clopidogrel. Insights from the ELEVATE-TIMI 56 Trial
Edward T Carreras, Willibald Hochholzer, Andrew L Frelinger, et al.
European Heart Journal. Acute Cardiovascular Care
|
January 14, 2016
Impact of residual platelet reactivity on reperfusion in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
Piera Capranzano, Davide Capodanno, Chiara Bucciarelli-Ducci, et al.
BMJ Open Diabetes Research & Care
|
February 27, 2021
Effects of D-allulose on glucose tolerance and insulin response to a standard oral sucrose load: results of a prospective, randomized, crossover study
Francesco Franchi, Dmitry M Yaranov, Fabiana Rollini, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
September 14, 2021
Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
Luis Ortega-Paz, Mattia Galli, Davide Capodanno, et al.
Journal of Thrombosis and Thrombolysis
|
August 18, 2019
Pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid-aspirin complex: results of a randomized, crossover, bioequivalence study
Dominick J Angiolillo, Deepak L Bhatt, Frank Lanza, et al.
Journal of the American College of Cardiology
|
August 7, 2007
Quantitative magnetic resonance perfusion imaging detects anatomic and physiologic coronary artery disease as measured by coronary angiography and fractional flow reserve
Marco A Costa, Steven Shoemaker, Hideki Futamatsu, et al.
Thrombosis and Haemostasis
|
July 12, 2012
Effects of pioglitazone on platelet P2Y12-mediated signalling in clopidogrel-treated patients with type 2 diabetes mellitus
Siva Suryadevara, Masafumi Ueno, Antonio Tello-Montoliu, et al.
Page
of 76
Search research articles
Search
Showing results (421-430 of 760) with videos related to
Sort By:
Page
of 76
Thrombosis Research
|
July 16, 2014
The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: a retrospective analysis of the FEATHER study
Joseph A Jakubowski, Dominick J Angiolillo, Chunmei Zhou, et al.
Journal of the American Heart Association
|
March 31, 2017
Impact of Diabetes Mellitus on the Pharmacodynamic Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Acute Coronary Syndrome Patients Undergoing Ad Hoc Percutaneous Coronary Intervention
Joseph M Sweeny, Dominick J Angiolillo, Francesco Franchi, et al.
Seminars in Thrombosis and Hemostasis
|
October 12, 2022
COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment
Luis Ortega-Paz, Azita H Talasaz, Parham Sadeghipour, et al.
Thrombosis and Haemostasis
|
March 25, 2016
Diabetes mellitus, CYP2C19 genotype, and response to escalating doses of clopidogrel. Insights from the ELEVATE-TIMI 56 Trial
Edward T Carreras, Willibald Hochholzer, Andrew L Frelinger, et al.
European Heart Journal. Acute Cardiovascular Care
|
January 14, 2016
Impact of residual platelet reactivity on reperfusion in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
Piera Capranzano, Davide Capodanno, Chiara Bucciarelli-Ducci, et al.
BMJ Open Diabetes Research & Care
|
February 27, 2021
Effects of D-allulose on glucose tolerance and insulin response to a standard oral sucrose load: results of a prospective, randomized, crossover study
Francesco Franchi, Dmitry M Yaranov, Fabiana Rollini, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
September 14, 2021
Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
Luis Ortega-Paz, Mattia Galli, Davide Capodanno, et al.
Journal of Thrombosis and Thrombolysis
|
August 18, 2019
Pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid-aspirin complex: results of a randomized, crossover, bioequivalence study
Dominick J Angiolillo, Deepak L Bhatt, Frank Lanza, et al.
Journal of the American College of Cardiology
|
August 7, 2007
Quantitative magnetic resonance perfusion imaging detects anatomic and physiologic coronary artery disease as measured by coronary angiography and fractional flow reserve
Marco A Costa, Steven Shoemaker, Hideki Futamatsu, et al.
Thrombosis and Haemostasis
|
July 12, 2012
Effects of pioglitazone on platelet P2Y12-mediated signalling in clopidogrel-treated patients with type 2 diabetes mellitus
Siva Suryadevara, Masafumi Ueno, Antonio Tello-Montoliu, et al.
Page
of 76